- Home
- FINW vs TLSA Comparison
FINW vs TLSA Comparison
Compare FINW & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- TLSA
- Stock Information
- Founded
- FINW 1999
- TLSA 2013
- Country
- FINW United States
- TLSA United Kingdom
- Employees
- FINW N/A
- TLSA N/A
- Industry
- FINW Commercial Banks
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- FINW Finance
- TLSA Health Care
- Exchange
- FINW Nasdaq
- TLSA Nasdaq
- Market Cap
- FINW 196.2M
- TLSA 187.0M
- IPO Year
- FINW 2021
- TLSA 2000
- Fundamental
- Price
- FINW $15.67
- TLSA $1.50
- Analyst Decision
- FINW Buy
- TLSA
- Analyst Count
- FINW 4
- TLSA 0
- Target Price
- FINW $20.75
- TLSA N/A
- AVG Volume (30 Days)
- FINW 76.0K
- TLSA 260.9K
- Earning Date
- FINW 07-24-2025
- TLSA 07-15-2025
- Dividend Yield
- FINW N/A
- TLSA N/A
- EPS Growth
- FINW N/A
- TLSA N/A
- EPS
- FINW 0.91
- TLSA N/A
- Revenue
- FINW $72,056,000.00
- TLSA N/A
- Revenue This Year
- FINW $38.17
- TLSA N/A
- Revenue Next Year
- FINW $18.44
- TLSA N/A
- P/E Ratio
- FINW $17.21
- TLSA N/A
- Revenue Growth
- FINW 7.66
- TLSA N/A
- 52 Week Low
- FINW $10.29
- TLSA $0.63
- 52 Week High
- FINW $20.94
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- FINW 66.33
- TLSA 48.99
- Support Level
- FINW $13.81
- TLSA $1.53
- Resistance Level
- FINW $14.37
- TLSA $1.81
- Average True Range (ATR)
- FINW 0.55
- TLSA 0.11
- MACD
- FINW 0.22
- TLSA -0.01
- Stochastic Oscillator
- FINW 89.53
- TLSA 11.76
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.